Vigonvita Life Sciences Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals: Generic
  • ISIN: CNE1000076N3
HKD
66.60
14.5 (27.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals: Generic

stock-summary
Market cap

HKD 9,846 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

-72.73%

stock-summary
Price to Book

19.81

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-21.09%
0%
-21.09%
6 Months
-28.0%
0%
-28.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Vigonvita Life Sciences Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-29.20%
EBIT Growth (5y)
-764.51%
EBIT to Interest (avg)
-12.20
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.61%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.53
EV to EBIT
-12.01
EV to EBITDA
-13.69
EV to Capital Employed
7.10
EV to Sales
39.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-59.13%
ROE (Latest)
-72.73%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
Bollinger Bands
Bearish
KST
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Vigonvita Life Sciences Co., Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 764.84% vs -94.20% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -64.11% vs -3,423.94% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "110.70",
          "val2": "12.80",
          "chgp": "764.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-318.10",
          "val2": "-186.00",
          "chgp": "-71.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "14.50",
          "val2": "17.50",
          "chgp": "-17.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-25.80",
          "val2": "-6.60",
          "chgp": "-290.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-387.30",
          "val2": "-236.00",
          "chgp": "-64.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,274.10%",
          "val2": "-17,203.80%",
          "chgp": "1,392.97%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
110.70
12.80
764.84%
Operating Profit (PBDIT) excl Other Income
-318.10
-186.00
-71.02%
Interest
14.50
17.50
-17.14%
Exceptional Items
-25.80
-6.60
-290.91%
Consolidate Net Profit
-387.30
-236.00
-64.11%
Operating Profit Margin (Excl OI)
-3,274.10%
-17,203.80%
1,392.97%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 764.84% vs -94.20% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -64.11% vs -3,423.94% in Dec 2024

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details